[Superiority of iodixanole vs hypoosmolar contrasts in the prevention of contrast-induced nephropathy in patients at risk: myth or reality?].

Recio-Mayoral Alejandro

Med Clin (Barc). 2010 Sep 11;135(8):362-4. doi: 10.1016/j.medcli.2010.03.029. Epub 2010 Jun 16.

Abstract

摘要

相似文献

Med Clin (Barc). 2010 Sep 11;135(8):362-4. doi: 10.1016/j.medcli.2010.03.029. Epub 2010 Jun 16.

Am J Med. 2007 Aug;120(8):e9; author reply e11. doi: 10.1016/j.amjmed.2006.02.035.

J Am Coll Cardiol. 2007 Feb 27;49(8):922; author reply 922-3. doi: 10.1016/j.jacc.2006.12.002. Epub 2007 Feb 8.

J Med Liban. 2007 Jan-Mar;55(1):29-38.

Nephrol Dial Transplant. 2008 Jul;23(7):2424; author reply 2424-5. doi: 10.1093/ndt/gfn163. Epub 2008 Apr 29.

JACC Cardiovasc Interv. 2009 Nov;2(11):1163-4; author reply 1164. doi: 10.1016/j.jcin.2009.08.022.

Indian Heart J. 2004 Jan-Feb;56(1):13-20.

Dtsch Med Wochenschr. 2006 May 5;131(18):1050; author reply 1051. doi: 10.1055/s-2006-939895.

Dtsch Med Wochenschr. 1995 Jun 2;120(22):806-10. doi: 10.1055/s-2008-1055412.

Expert Rev Cardiovasc Ther. 2006 Sep;4(5):655-61. doi: 10.1586/14779072.4.5.655.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00323-17. Print 2017 Aug.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。